We observed that treating infected macrophages with TNFR neutralizing antibodies decreased mTOR phosphorylation at Ser-2448 (Fig 6A and 6B), as previously reported for cancer cells [49]; it also reduced expression of SREBF1, an mTORC1-activated gene (Fig 6C). The gene discussed is SREBF1; the disease is cancer.